Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 28

Trial Status

Completed9

Role Distribution

Principal Investigator1
Other Roles8
PI Rate11%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerCancer of KidneyUrinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Prostate CancerMetastatic CancerSarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of KidneyUrinary Bladder CancerMetastatic Cancer

Worked with same sponsors:

Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)
Similarity Score13%

Chi Fai Ng, MD

Chinese University of Hong Kong

Related
30 trials

Shared therapeutic areas:

Prostate CancerUrinary Bladder CancerCancer of Kidney
Similarity Score13%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Urinary Bladder CancerSarcoma
Similarity Score9%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Prostate CancerSarcoma
Similarity Score9%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney
Similarity Score9%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Prostate CancerMetastatic Cancer

Worked with same sponsors:

Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)
Similarity Score9%

Lorenzo Cohen, PhD

M.D. Anderson Cancer Center

Related
17 trials

Shared therapeutic areas:

Cancer of KidneyProstate Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT00004203Phase 2StudyChair

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Completed
NCT00005066Phase 2StudyChair

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Sarcoma
Completed
NCT00005086Phase 2StudyChair

Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer

Bladder Cancer
Completed
NCT00006002Phase 2StudyChair

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer
Completed
NCT00006105Phase 2StudyChair

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Bladder CancerDrug/Agent Toxicity by Tissue/Organ
Completed
NCT00025376Phase 2StudyChair

PS-341 in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
Completed
NCT00026377Phase 1StudyChair

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer
Completed
NCT00042965Phase 2StudyChair

Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
Completed
NCT00301847Phase 2PrincipalInvestigator

Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Kidney CancerMetastatic Cancer
Completed

All 9 trials loaded